Genomic Characterisation and In Vivo Therapeutic Evaluation of the Novel Phage Lp ACM616_1 Targeting Lactococcus petauri
Journal of Fish Diseases · 2026
DOI: 10.1111/jfd.70124 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Fish Diseases, 2026. Verfasst von Ilhan Altinok und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Fisheries Technology Engineering, Faculty of Marine Sciences, Karadeniz Technical University, Trabzon, Türkiye. Hauptthemen laut MEDLINE: Lactococcus, Phage Therapy, Bacteriophages, Fish Diseases. Die Arbeit nennt 80 Literaturangaben. Gefördert von: Karadeniz Teknik Üniversitesi.
Abstract (Originalsprache)
Piscine lactococcosis, a major bacterial disease in aquaculture causing haemorrhagic septicaemia and economic losses, was traditionally attributed to Lactococcus garvieae but now includes emerging pathogens like Lactococcus petauri . Amid rising antibiotic resistance, bacteriophage therapy offers a sustainable alternative. This study aimed to isolate, characterise, and evaluate the therapeutic potential of a lytic phage targeting L. petauri . Phage Lp ACM616_1 was isolated from aquaculture effluents in Türkiye using L. petauri as the host. Whole‐genome analysis and transmission electron microscopy were used to identify it as a member of the Caudoviricetes class. It has an icosahedral head (~31 nm) and a long tail (~107 nm). Host range testing showed specificity to 10 of 11 L. petauri strains, with no activity against other pathogens. Lp ACM616_1 exhibited robust stability (70%–90% viability at −20°C to 50°C; > 75% at pH 4–10), rapid adsorption (> 85% in 30 min), a 10–20 min latent period, and high burst size. In vitro, it suppressed bacterial growth at low MOIs and showed no cytotoxicity in EPC cells. Genomic characterisation revealed a 23,157 bp double‐stranded DNA genome with 36.3% GC content and 40 predicted coding sequences, supporting its classification as a novel species within the genus Chertseyvirus lacking virulence and antimicrobial resistance genes. In rainbow trout challenge trials, intraperitoneal phage injection of the phage post‐infection significantly improved survival to 77% compared to 40% in the untreated control group. In contrast, oral delivery via feed was found to be ineffective, yielding a survival rate of 42%. This first L. petauri ‐specific phage demonstrates promising biocontrol potential, advocating for cocktails and encapsulation to enhance aquaculture applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Fisheries Technology Engineering, Faculty of Marine Sciences, Karadeniz Technical University, Trabzon, Türkiye.
- Department of Chemistry C Block, Aquatic Animal Health and Molecular Genetics (AQUANETIC) Lab, Trabzon, Türkiye.
- Institute of Marine Sciences and Technology, Karadeniz Technical University, Trabzon, Türkiye.
- Fish Health Department, Central Fisheries Research Institute, Trabzon, Türkiye.
ORCID-Profile: Ilhan Altinok, Ayse Cebeci, Rafet Çağrı Öztürk
Förderung
- Karadeniz Teknik Üniversitesi
Zitieren
APA
Altinok, I., Ture, M., Ustaoglu, D., Cebeci, A., & Öztürk, R. Ç. (2026). Genomic Characterisation and In Vivo Therapeutic Evaluation of the Novel Phage Lp ACM616_1 Targeting Lactococcus petauri. Journal of Fish Diseases. https://doi.org/10.1111/jfd.70124
Vancouver
Altinok I, Ture M, Ustaoglu D, Cebeci A, Öztürk RÇ. Genomic Characterisation and In Vivo Therapeutic Evaluation of the Novel Phage Lp ACM616_1 Targeting Lactococcus petauri. Journal of Fish Diseases. 2026. doi:10.1111/jfd.70124
BibTeX
@article{Altinok2026,
author = {Altinok, Ilhan and Ture, Mustafa and Ustaoglu, Dilek and Cebeci, Ayse and Öztürk, Rafet Çağrı},
title = {Genomic Characterisation and In Vivo Therapeutic Evaluation of the Novel Phage Lp ACM616_1 Targeting Lactococcus petauri},
journal = {Journal of Fish Diseases},
year = {2026},
doi = {10.1111/jfd.70124}
}
EUVIMED